管理心力衰竭患者的肥胖:当前的证据和策略
Shriya Sharma1, Ganesh Giri2, Aarti Desai1
1Division of Advanced Heart Failure and Transplantation, Mayo Clinic in Florida.
The American journal of cardiology
|February 12, 2026
概括
肥胖严重影响心力衰竭患者,增加健康风险. 通过多学科策略来管理肥胖症可以改善心力衰竭中的生活质量和功能状态.
科学领域:
- 心脏病学 心脏病学
- 代谢障碍 代谢障碍 代谢障碍
- 公共卫生 公共卫生
背景情况:
- 肥胖,定义为多余的脂肪组织,是一个主要的全球健康问题.
- 它与糖尿病,心血管疾病,高血压和炎症有关,增加心力衰竭风险.
- 预计到2035年,肥胖患病率将大幅上升.
研究的目的:
- 审查当前关于管理心力衰竭患者肥胖的证据.
- 探索肥胖对心力衰竭并发症的影响.
- 讨论适合肥胖心力衰竭患者的先进治疗选择.
主要方法:
- 这是一个复习文章.
- 它综合了现有的关于心力衰竭中肥胖管理的研究.
- 它研究了多学科的治疗策略和先进疗法.
主要成果:
- 肥胖会通过心血管事件,胰岛素抵抗和炎症加剧心力衰竭.
- 多学科管理,包括物理治疗,营养,药物治疗和减肥手术,可以改善患者的治疗结果.
- 解决肥胖症可以提高心力衰竭患者的功能状态和生活质量.
结论:
- 有效的肥胖管理对于心力衰竭患者至关重要.
- 多学科的方法对于综合护理至关重要.
- 对于某些患有终端心力衰竭和肥胖症的患者,可以考虑进行心脏移植或LVAD等先进疗法.
相关概念视频
Heart Failure V: Medical Management
363
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
363
Heart Failure II: Pathophysiology
1.0K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.0K
Drug Dosing: Obese Patients
269
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
269
Pathophysiology of Heart Failure
4.0K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.0K
Heart Failure I: Introduction
958
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
958
Heart Failure VI: Adjunct Therapies
399
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
399


